Search research articles
Contact Us
Filters
Showing results (51-60 of 201) with videos related to
Page
of 21
Sort By:
American Journal of Therapeutics
|
February 15, 2011
Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy
Eric Q Wu, Anna Forsythe, Annie Guérin, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 27, 2017
Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database Analysis
Amy Guo, Alexander Niyazov, Dendy Macaulay, et al.
Current Medical Research and Opinion
|
January 26, 2018
The prevalence of hyperkalemia in the United States
Keith A Betts, J Michael Woolley, Fan Mu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 8, 2014
Impact of timely switching from imatinib to a second-generation tyrosine kinase inhibitor after 12-month complete cytogenetic response failure: a chart review analysis
Daniel J DeAngelo, Lei Chen, Annie Guerin, et al.
Breast Cancer : Basic and Clinical Research
|
September 19, 2015
Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2- Metastatic Breast Cancer
Yan Song, Yanni Hao, Alexander R Macalalad, et al.
Expert Opinion on Pharmacotherapy
|
August 21, 2015
Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA
Peggy L Lin, Yanni Hao, Jipan Xie, et al.
Clinical Therapeutics
|
March 8, 2016
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2- mBC Patients With Multiple Metastatic Sites
Nanxin Li, Yanni Hao, Jipan Xie, et al.
Rheumatology and Therapy
|
October 18, 2016
Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis
Keith A Betts, Jenny Griffith, Yan Song, et al.
Journal of Medical Economics
|
November 17, 2012
Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers with epidermal growth factor receptor inhibitors
Saurabh Ray, Vijayveer Bonthapally, Kyle D Holen, et al.
Pharmacoeconomics
|
July 14, 2012
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents
Vanja Sikirica, M Haim Erder, Jipan Xie, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 201) with videos related to
Sort By:
Page
of 21
American Journal of Therapeutics
|
February 15, 2011
Comorbidity burden, healthcare resource utilization, and costs in chronic gout patients refractory to conventional urate-lowering therapy
Eric Q Wu, Anna Forsythe, Annie Guérin, et al.
Journal of Managed Care & Specialty Pharmacy
|
June 27, 2017
Inpatient Admissions and Costs Associated with Persistent Use of Dalfampridine Extended-Release in Multiple Sclerosis: A Claims Database Analysis
Amy Guo, Alexander Niyazov, Dendy Macaulay, et al.
Current Medical Research and Opinion
|
January 26, 2018
The prevalence of hyperkalemia in the United States
Keith A Betts, J Michael Woolley, Fan Mu, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 8, 2014
Impact of timely switching from imatinib to a second-generation tyrosine kinase inhibitor after 12-month complete cytogenetic response failure: a chart review analysis
Daniel J DeAngelo, Lei Chen, Annie Guerin, et al.
Breast Cancer : Basic and Clinical Research
|
September 19, 2015
Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2- Metastatic Breast Cancer
Yan Song, Yanni Hao, Alexander R Macalalad, et al.
Expert Opinion on Pharmacotherapy
|
August 21, 2015
Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA
Peggy L Lin, Yanni Hao, Jipan Xie, et al.
Clinical Therapeutics
|
March 8, 2016
Effectiveness of Everolimus Versus Endocrine Monotherapy or Chemotherapy Among HR+/HER2- mBC Patients With Multiple Metastatic Sites
Nanxin Li, Yanni Hao, Jipan Xie, et al.
Rheumatology and Therapy
|
October 18, 2016
Network Meta-Analysis and Cost Per Responder of Tumor Necrosis Factor-α and Interleukin Inhibitors in the Treatment of Active Ankylosing Spondylitis
Keith A Betts, Jenny Griffith, Yan Song, et al.
Journal of Medical Economics
|
November 17, 2012
Economic burden of dermatologic adverse drug reactions in the treatment of colorectal, non-small cell lung, and head and neck cancers with epidermal growth factor receptor inhibitors
Saurabh Ray, Vijayveer Bonthapally, Kyle D Holen, et al.
Pharmacoeconomics
|
July 14, 2012
Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents
Vanja Sikirica, M Haim Erder, Jipan Xie, et al.
Page
of 21